SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-25-004443
Filing Date
2025-01-10
Accepted
2025-01-10 16:06:34
Documents
15
Period of Report
2025-01-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d898488d8k.htm   iXBRL 8-K 28169
2 EX-3.1 d898488dex31.htm EX-3.1 5183
3 EX-3.2 d898488dex32.htm EX-3.2 111733
  Complete submission text file 0001193125-25-004443.txt   295593

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rntx-20250110.xsd EX-101.SCH 2513
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rntx-20250110_lab.xml EX-101.LAB 18700
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rntx-20250110_pre.xml EX-101.PRE 11685
18 EXTRACTED XBRL INSTANCE DOCUMENT d898488d8k_htm.xml XML 4009
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Rein Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38130 | Film No.: 25522911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)